SCHEMBL8844809

SCHEMBL8844809

Cc1c(Cl)cccc1-n1nnc2ccccc21

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KCNMA1 Q12791 1/20 0.55
TSHR P16473 3/20 0.47
ALDH1A1 P00352 3/20 0.47
SMN1; SMN2 Q16637 3/20 0.44
KMT2A Q03164 2/20 0.44
RAB9A P51151 1/20 0.44
GAA P10253 3/20 0.44
SLC9A1 P19634 2/20 0.43
KEAP1 Q14145 1/20 0.43
KDM4E B2RXH2 2/20 0.42
LMNA P02545 1/20 0.41
RECQL P46063 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
HSD17B10 Q99714 1/20 0.41
POLB P06746 1/20 0.41
MGAM O43451 2/20 0.40
AMY1A P0DUB6 2/20 0.40
SI P14410 2/20 0.40
MGAM2 Q2M2H8 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25862494 0.89 KCNMA1 (0.64) KCNMA1TSHRALDH1A1SMN1; SMN2KMT2A
SCHEMBL25078456 0.84 KCNMA1 (0.58) KCNMA1TSHRALDH1A1SMN1; SMN2KMT2A
SCHEMBL23840194 0.82 KCNMA1 (0.64) KCNMA1TSHRALDH1A1SMN1; SMN2KMT2A
SCHEMBL25021088 0.81 KCNMA1 (0.55) KCNMA1TSHRALDH1A1SMN1; SMN2KMT2A
SCHEMBL23901402 0.80 KCNMA1 (0.47) KCNMA1TSHRALDH1A1SMN1; SMN2KMT2A
SCHEMBL23349069 0.79 KCNMA1 (0.53) KCNMA1TSHRALDH1A1SMN1; SMN2KMT2A
SCHEMBL8233645 0.78 KCNMA1 (0.46) KCNMA1TSHRALDH1A1SMN1; SMN2KMT2A
SCHEMBL4209963 0.78 KCNMA1 (0.64) KCNMA1TSHRALDH1A1SMN1; SMN2KMT2A
SCHEMBL14536274 0.76 SMN1; SMN2 (0.49) KCNMA1TSHRALDH1A1SMN1; SMN2KMT2A
SCHEMBL25020407 0.75 KCNMA1 (0.55) KCNMA1TSHRALDH1A1SMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4347544-A1 PROCESSES FOR THE VAPOR PHASE HYDROGENATION OF ALDEHYDES Dow Technology Investments LLC (US) 2024-04-10 EP disclosed
WO-2022250790-A1 PROCESSES FOR THE VAPOR PHASE HYDROGENATION OF ALDEHYDES DOW TECHNOLOGY INVESTMENTS LLC (US) 2022-12-01 WO disclosed
EP-3543242-A1 8,9-DIHYDROIMIDAZOLE[1,2-A]PYRIMIDO[5,4-E]PYRIMIDINE-5(6H)-KETONE COMPOUND Impact Therapeutics, Inc (CN) 2019-09-25 EP disclosed
EP-2970074-A1 HETEREOCYCLIC AGENT AS CATALYTIC STABILIZING AGENT IN A HYDROFORMYLATION PROCESS Dow Technology Investments LLC (US) 2016-01-20 EP disclosed
WO-2014149915-A1 HETEREOCYCLIC AGENT AS CATALYTIC STABILIZING AGENT IN A HYDROFORMYLATION PROCESS DOW TECHNOLOGY INVESTMENTS LLC (US) 2014-09-25 WO disclosed
WO-1997020798-A1 IMPROVED METAL-LIGAND COMPLEX CATALYZED PROCESSES UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 1997-06-12 WO disclosed